Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder CancerVedang Murthy, Priyamvada Maitre, Mahendra Pal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Sadhana Kannan, et al.International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.Cancer|March 13, 2016
Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based studyRahul Krishnatry, Nataliya Zhukova, Ana S Guerreiro Stucklin, et al.The Lancet. Oncology|January 22, 2026
Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trialLisa M Wintner, Monika Sztankay, Hikmat Abdel-Razeq, et al.JAMA Oncology|July 3, 2024
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical TrialVikas Ostwal, Shraddha Patkar, Reena Engineer, et al.Indian Journal of Cancer|March 1, 2024
Tata Memorial Centre Evidence Based Management of Colorectal cancerAvanish Saklani, Mufaddal Kazi, Ashwin Desouza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium StudyAlvaro Lassaletta, Katrin Scheinemann, Shayna M Zelcer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade gliomaMatthew Mistry, Nataliya Zhukova, Daniele Merico, et al.Pageof 9